J. Dean Zikria
Interim CEO & DirectorMr. J. Dean Zikria is Interim CEO of Valion Bio, Inc. (formerly known as Tivic Health Systems, Inc.) from September 22, 2026 and has been its Director since July 10, 2019 and was its Independent Director since July 10, 2019 until September 22, 2026. He serves as an Advisor at Berkeley Skydeck Fund. He has served as a Chief Commercial Officer and served as Senior Vice President of Sales and Marketing at Intuity Medical, Inc. since June 1, 2021 until January 2023. In addition, he has served as Chairman of DZ Advisors, LLC where he also served as President from December 2017 until May 31, 2021. Mr. Zikira also sits on the boards of the following privately held companies: AsthmaTek, Inc., Paneau Inc., Brev.Dev, Inc. and Mind Machine LLC. Mr. Zikria is also on the scientific advisory board of Bailard, Inc. From 2019 to 2021, Mr. Zikria served as the CEO of Mind Machine LLC, where he was also the Founder and also served as a Chairman. He served as CEO of Spirosure Inc. from 2014 to 2017. He served as head of global marketing for Johnson & Johnson’s Animas Corporation within their medical device & diagnostics division. He was head of strategy for Pfizer Pharmaceuticals U.S. Cardiovascular Unit. Mr. Zikria has an experience in strategic planning, scenario planning and analysis and mergers and acquisitions, including sourcing, transactions and integration. Mr. Zikria holds a Bachelor of Science in Biology from Rutgers University: Cook College and a Master of Business Administration from Rutgers Graduate School of Management.
Positions
- Company NameValion Bio, Inc.Stock CodeVBIOPositionInterim CEO & Director
